STOCK TITAN

Henry Schein (HSIC) director Carole T. Faig receives 2,577 RSU grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Faig Carole T reported acquisition or exercise transactions in this Form 4 filing.

Henry Schein director Carole T. Faig received an equity grant from the company. She was awarded 2,577 restricted stock units relating to common stock at a stated price of $0.00 per share as a grant or award.

According to the grant terms, these restricted stock units were issued under Henry Schein's 2023 Non-Employee Director Stock Incentive Plan and generally vest after a 12‑month cliff period, conditioned on her continued service to the company. Following this award, her directly held common stock-related holdings total 8,025 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Faig Carole T

(Last) (First) (Middle)
C/O HENRY SCHEIN, INC.
135 DURYEA ROAD

(Street)
MELVILLE NY 11747

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HENRY SCHEIN INC [ HSIC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock par value $0.01 per share 03/06/2026 A 2,577(1) A $0 8,025 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired pursuant to the Issuer's 2023 Non-Employee Director Stock Incentive Plan. Subject to certain exceptions, such restricted stock units will vest subject to (i) the passage of a specified period of time (12-months cliff vesting) and (ii) the reporting person's continued performance of services for the Issuer.
/s/ Jennifer Ferrero (as attorney-in-fact for Carole T. Faig) 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Henry Schein (HSIC) director Carole T. Faig report on this Form 4?

Carole T. Faig reported receiving 2,577 restricted stock units relating to Henry Schein common stock as an equity grant. The award was made at a stated price of $0.00 per share under the company’s 2023 Non-Employee Director Stock Incentive Plan.

How many Henry Schein (HSIC) shares does Carole T. Faig own after this grant?

After the reported grant, Carole T. Faig directly holds 8,025 shares or share-equivalent units of Henry Schein common stock. This total reflects the addition of 2,577 restricted stock units received under the company’s 2023 Non-Employee Director Stock Incentive Plan.

What type of transaction was reported in this Henry Schein (HSIC) Form 4?

The Form 4 reports an acquisition classified as a grant or award of equity, coded “A.” Carole T. Faig received 2,577 restricted stock units at a stated price of $0.00 per share under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan.

What are the vesting terms of Carole T. Faig’s Henry Schein (HSIC) restricted stock units?

The restricted stock units generally vest after a 12‑month cliff period, subject to certain exceptions. Vesting also depends on Carole T. Faig’s continued performance of services for Henry Schein, as provided under the 2023 Non-Employee Director Stock Incentive Plan.

Does this Henry Schein (HSIC) Form 4 indicate a stock purchase or sale by Carole T. Faig?

The Form 4 does not show an open market purchase or sale. Instead, it records an equity award, where Carole T. Faig acquired 2,577 restricted stock units at a stated price of $0.00 under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan.
Henry Schein, Inc.

NASDAQ:HSIC

View HSIC Stock Overview

HSIC Rankings

HSIC Latest News

HSIC Latest SEC Filings

HSIC Stock Data

8.90B
98.34M
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
MELVILLE